| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(87)90233-9 |
| P698 | PubMed publication ID | 2881131 |
| P2093 | author name string | A Ting | |
| J F Thompson | |||
| P J Morris | |||
| R D Allen | |||
| J R Chapman | |||
| R F Wood | |||
| M S Dunnill | |||
| P2860 | cites work | Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples | Q24569561 |
| Cyclosporin and renal graft histology | Q39558964 | ||
| Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers | Q39574059 | ||
| Alterations in lipid and carbohydrate metabolism attributable to cyclosporin A in renal transplant recipients. | Q41833354 | ||
| Post-transplant acute renal failure in cadaver renal recipients treated with cyclosporine | Q44776777 | ||
| Sequential analysis of HLA-class II antigen expression in human renal allografts. Induction of tubular class II antigens and correlation with clinical parameters | Q68892404 | ||
| Reversibility of cyclosporin nephrotoxicity after three months' treatment | Q69856306 | ||
| Cyclosporin forever? | Q69880856 | ||
| Cyclosporin treatment with conversion after three months versus conventional immunosuppression in renal allograft recipients | Q69895026 | ||
| Elective conversion from cyclosporine to azathioprine in recipients with stable renal function 6 months after kidney transplantation | Q69913492 | ||
| Some observations on the quantitative anatomy of the kidney | Q70001143 | ||
| A controlled trial of cyclosporine in renal transplantation with conversion to azathioprine and prednisolone after three months | Q70161611 | ||
| Conversion from cyclosporine to azathioprine in renal allograft recipients | Q70399268 | ||
| P433 | issue | 8533 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 586-591 | |
| P577 | publication date | 1987-03-01 | |
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Cyclosporin conversion versus conventional immunosuppression: long-term follow-up and histological evaluation | |
| P478 | volume | 1 |
| Q72648752 | Beneficial effects of conversion from cyclosporin to azathioprine after kidney transplantation |
| Q90292080 | Biological effects of cyclosporin A on CD3-CD161+ and CD3+CD161+ lymphocytes |
| Q38668601 | Calcineurin inhibitor withdrawal or tapering for kidney transplant recipients. |
| Q79299840 | Cyclosporin A (CsA) and azathioprine (AZA) combination in renal allografts with CsA nephrotoxicity |
| Q35675934 | Cyclosporine: a review |
| Q69522631 | Determination of cyclosporin A in the serum of kidney transplant patients by rapid-flow fractionation and normal-phase high-performance liquid chromatography |
| Q41834576 | Late kidney dysfunction in a kidney transplant recipient |
| Q38015284 | Principles of immunosuppression. |
| Q43738507 | Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomised controlled study |
| Q69480604 | Safe conversion from cyclosporine to azathioprine with improved renal function in pediatric renal transplantation |
| Q36722589 | Ten Tanzanian transplants: problems and perspectives |
| Q33647985 | The lens after renal transplantation |
| Q68851806 | Triple therapy immunosuppression in cadaveric renal transplantation |
Search more.